Informational:Informational:For Research Use Only. Not for use in diagnostic procedures.
Informational:Informational:100% knock-in using CRISPR-Cas9—try our new TrueTag Donor DNA Kits for GFP, RFP or luciferase tagging.
Invitrogen™

LentiArray™ CRISPR Positive Control Lentivirus, human HPRT

Catalog number: A32056
Related applications: Pharma & Biopharma
Technical SupportCustomer Service
Product Image
Invitrogen™

LentiArray™ CRISPR Positive Control Lentivirus, human HPRT

Catalog number: A32056
Related applications: Pharma & Biopharma
Technical SupportCustomer Service
Catalog Number
A32056
Unit Size
100 µL
Price (USD)
400.00
Your Price:
Availability
***
Quantity
Catalog Number
A32829
Unit Size
1 mL
Price (USD)
1,718.00
Your Price:
Availability
***
Quantity
Catalog NumberUnit SizePrice (USD)AvailabilityQuantity
A32056100 µL
400.00
Your Price:
***
A328291 mL
1,718.00
Your Price:
***
Product Overview
Figures
Videos
Documents
FAQ
Citations & References
Additional Information
Recommendations
Recommendations
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
For Research Use Only. Not for use in diagnostic procedures.

Specifications

Control Type
Positive Control
Delivery Type
Lentiviral
For Use With (Application)
CRISPR gene knockout
Product Line
LentiArray™
Product Type
CRISPR Positive Control Lentivirus
Quantity
100 μL
Shipping Condition
Dry Ice
Promoter
U6
Species
Human
Transfection Technique
Lentiviral transduction

Contents & Storage

1 x 100 µL. Store (at -68°C to -85°C.)

Figures

Standard gene editing workflow using CRISPR-Cas9 technology
Standard gene editing workflow using CRISPR-Cas9 technology
CRISPR RNP—streamlined editing and minimization of off-target events
CRISPR RNP—streamlined editing and minimization of off-target events
A CRISPR-Cas9 targeted double-strand break
A CRISPR-Cas9 targeted double-strand break
Engineered nuclease—various double strand repair pathways
Engineered nuclease—various double strand repair pathways
Kinases screened in CellSensor cells with a ratiometric two-color reporter assay
Kinases screened in CellSensor cells with a ratiometric two-color reporter assay
LentiArray Cas9 Lentivirus map
LentiArray Cas9 Lentivirus map
Delivery controls
Delivery controls
Factors affecting genome editing efficiency outcomes
Factors affecting genome editing efficiency outcomes